Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22M Buy
10,273
+4,858
+90% +$929K 0.03% 305
2026
Q1
$993K Buy
+5,415
New +$998K 0.02% 327
2025
Q2
Sell
-57
Closed -$7.8K 113
2025
Q1
$7.8K Buy
+57
New +$8.15K 0.04% 368

Other funds holding BIIB

Saudi Central Bank's BIIB Position: Q2 2026 in Review

Saudi Central Bank increased its Biogen (BIIB) stake by 90% in Q2 2026, buying an estimated $929K and bringing the position to 10,273 shares worth $2.22M. The position accounts for 0.03% of the portfolio, ranked #305.

Saudi Central Bank first reported a position in BIIB in Q1 2025 and has held it in 3 quarters since. 380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Saudi Central Bank held 10,273 shares of Biogen worth $2.22M as of Q2 2026.
  • Saudi Central Bank bought 4,858 Biogen shares in Q2 2026, an estimated $929K.
  • Biogen made up 0.03% of Saudi Central Bank's portfolio in Q2 2026, its #305 holding.
  • Saudi Central Bank first reported a position in Biogen in Q1 2025 and has held it in 3 quarters since.
  • 380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.